Investors in mainland China and Hong Kong may be unable to take part in Anthropic’s initial public offering. Multiple banks have reportedly rejected their buy orders or consider allocations to them unlikely, with some people involved citing US export controls as the reason.
Export controls shape access to the offering
The reported concern centers on ITAR, the US export control rules governing defense-related goods. Some people involved in the offering cited those rules when explaining why banks were rejecting orders or viewing allocations as unlikely.
The report does not say that every bank has made the same decision, or that all investors from those regions have been formally barred. It describes buy orders being rejected by multiple banks and allocations being considered unlikely. That distinction matters: the reported outcome is a restriction on access through the offering, while the reasons and decisions described are attributed to people involved.
Anthropic declined to comment. The source does not provide a further explanation from the company about the reported screening or how the banks are applying the export control rules.
How the IPO is being organized
Goldman Sachs and Morgan Stanley are leading the offering, with 20 other banks involved. The stock is expected to trade on Nasdaq under the ticker ANT after pricing on November 18.
With many banks involved, the reported limits affect a broad offering process rather than a single bank’s order book. At the same time, the source gives no details on how many orders have been rejected, how many investors may be affected, or whether any allocation could still be made to investors in mainland China or Hong Kong.
The expected Nasdaq listing and ticker identify how the stock is planned to trade once priced. They do not, on their own, resolve questions about who can participate in the offering. The reported screening shows that access is a separate issue from the planned listing.
A wider tension in Anthropic’s China relationship
The company’s products are not officially available in China or Hong Kong, and its broader relationship with the country has been defined by confrontation. Anthropic has blocked firms under Chinese control from its AI services and is fighting workarounds that let Chinese companies access Claude Code.
Anthropic has also exposed large-scale distillation attacks by DeepSeek, Moonshot, and MiniMax, involving some 16 million queries. These details provide context for the strained relationship described in the source, but the report does not say that the attacks directly prompted the banks’ decisions about IPO orders.
Taken together, the reported investor screening and the company’s restrictions on service access show that Anthropic’s connections to China reach beyond product availability. The IPO account describes a separate financial access question, with banks reportedly weighing whether to accept orders from investors in mainland China and Hong Kong under US export control rules.
What remains unclear
The report leaves several practical questions open. It does not name the banks that rejected orders, explain whether all 20 other banks are taking the same approach, or detail the process each bank uses to assess an investor’s eligibility.
It also does not describe any final allocation decisions. For now, the information available is limited to the reported rejections and unlikely allocations, the cited role of ITAR, and the planned offering led by Goldman Sachs and Morgan Stanley. Anthropic’s decision not to comment leaves the company’s own position on these reports unstated.